Specialising in AI-enabled evidence generation, systematic literature reviews, and healthcare data strategy
Bioscript Group has been recognised with two honours at the British Data Awards 2026, reinforcing its role as a trusted partner in healthcare data, AI, and evidence generation.
Bioscript was named winner of the Best Place to Work in Data (Partner) award and was highly commended in the Healthcare Organisation of the Year category. The recognition highlights both the impact of Bioscript Data Insights (BDI), Bioscript’s specialist team for healthcare data analytics, AI, and evidence generation, and the culture that enables our people to deliver meaningful innovation for pharmaceutical partners.
Together, these achievements underline Bioscript’s growing role as a trusted partner for organisations seeking to accelerate evidence generation, integrate complex healthcare data, and apply AI responsibly to scientific and medical decision-making. For Bioscript Data Insights, the recognition marks an important moment in a year defined by technical progress, client impact, and team growth.
At a glance: Bioscript at the British Data Awards 2026
- Winner: Best Place to Work in Data (Partner)
- Highly commended: Healthcare Organisation of the Year
- Team: Bioscript Data Insights (BDI)
- Impact: Reduced evidence synthesis timelines by 75%
- Scale: Processed more than 47,000 records across systematic literature reviews
- Innovation: Developed Synapse, an AI-enabled platform for healthcare data integration
"These awards reflect the strength of the team we are building and the value we are delivering for clients. Healthcare data is becoming increasingly complex, and our role is to help pharmaceutical teams turn that complexity into evidence-led decisions with confidence."
Helping medical affairs teams turn complex data into actionable insight
Healthcare data is becoming increasingly complex, fragmented, and difficult to interpret at speed. Medical affairs and pharmaceutical teams are working across expanding volumes of congress outputs, publications, expert engagement data, real-world evidence and clinical insights.
Bioscript Data Insights helps teams navigate that complexity.
BDI combines data science, information science, public health expertise, and AI-enabled analytics to support evidence generation and insight development. The team works with pharmaceutical organisations to identify trends, structure evidence, connect data sources and generate insights that support more confident decision-making.
Our work, which was highly commended in the Healthcare Organisation of the Year category, reflects a broader programme of activity across healthcare data analytics, real-world evidence, systematic literature reviews and AI-enabled medical insight generation.
What this means in practice
Bioscript Data Insights supports pharmaceutical teams to:
- Identify emerging evidence trends from congresses and scientific meetings faster
- Generate structured insights from systematic literature reviews and meta-analyses
- Analyse real-world healthcare datasets alongside clinical and scientific evidence
- Integrate fragmented data sources across publications, congresses, expert networks, and real-world evidence
- Apply AI-enabled analytics responsibly to support evidence-led decision-making
This helps teams make faster evidence-led decisions, prioritise scientific opportunities, and understand emerging trends across therapy areas.
Delivering measurable impact in healthcare data and evidence generation
Over the past year, Bioscript Data Insights has delivered measurable progress across evidence synthesis, healthcare data integration, and advanced analytics.
Key impact includes:
- Delivering connected intelligence through Synapse, Bioscript’s AI-enabled healthcare data integration platform
- Integrating congress data, expert mapping, publication insights, and evidence data into a single connected view
- Supporting more than ten systematic literature reviews and meta-analyses
- Processing more than 47,000 records across systematic literature reviews
- Reducing evidence synthesis timelines by 75%
- Applying advanced analytics to real-world data to identify differences between patient-reported and physician-assessed outcomes
Synapse is Bioscript’s AI-enabled healthcare data integration platform for connecting congress, publication, expert, and evidence data. For medical affairs teams, this means faster access to connected evidence, clearer visibility of emerging scientific trends, and more informed engagement planning.
"Being shortlisted in five categories told us we were doing something right. Winning Best Place to Work in Data told us we were doing the right things in the right way. You can build a strong technical capability and still get the culture wrong - that's the harder bit to get right, and it's the one I am proudest of."
Recognised as a Best Place to Work in Data
Winning the Best Place to Work in Data (Partner) award reflects the culture that underpins Bioscript’s work in healthcare data science, evidence generation, and AI innovation.
Within BDI, we have built an environment grounded in trust, curiosity, collaboration and scientific rigour. This enables our team to explore innovative approaches while maintaining a strong focus on responsible, transparent and effective use of data and AI in healthcare.
This culture is also reflected in Bioscript’s Great Place to Work certification, where the organisation achieved an 84% trust score across wellbeing, leadership and opportunity.
Our multidisciplinary team brings together expertise in data science, public health, information science, evidence synthesis, and medical communications. This breadth of capability allows us to support clients with both technical innovation and scientific credibility.
"Sharing the stage with so many incredible teams was inspiring in itself, but to leave with recognition as the Best Place to Work in Data, and to be highly commended for our impact as a Healthcare Organisation, is something I’ll take genuine pride in."
Building the future of healthcare data, AI, and evidence generation
These awards mark an important milestone for Bioscript Data Insights. They recognise not only the technical progress we have made, but also the culture, collaboration and scientific focus behind that progress.
As healthcare organisations continue to manage increasing volumes of complex and fragmented data, the need for trusted, AI-enabled, evidence-led insight will only grow.
Bioscript will continue to invest at the intersection of data, science, and human expertise, helping medical affairs and pharmaceutical partners to:
- Accelerate evidence generation in healthcare
- Navigate complex, multi-source data environments
- Strengthen medical and scientific decision-making
- Identify emerging trends across therapy areas
- Apply AI-enabled analytics responsibly and transparently
- Generate insights that ultimately support better outcomes for patients
Frequently asked questions
What did Bioscript win at the British Data Awards 2026?
Bioscript Group won the Best Place to Work in Data (Partner) award and was highly commended in the Healthcare Organisation of the Year category at the British Data Awards 2026.
What is Bioscript Data Insights?
Bioscript Data Insights is Bioscript Group’s specialist healthcare data, AI, and evidence generation team. It supports pharmaceutical and healthcare organisations with data analytics, systematic literature reviews, real-world evidence, AI-enabled insights, and integrated evidence platforms.
How does Bioscript support medical affairs teams?
Bioscript supports teams by helping them generate evidence faster, integrate complex data sources, identify emerging scientific trends, and apply AI-enabled analytics to support evidence-led decision-making.
What impact has Bioscript delivered in healthcare data?
Over the past year, Bioscript has reduced evidence synthesis timelines by 75%, processed more than 47,000 records across systematic literature reviews, supported more than ten systematic literature reviews and meta-analyses, and developed platforms such as Synapse to integrate complex healthcare data.
What is Synapse in healthcare data?
Synapse is Bioscript’s AI-enabled healthcare data integration platform. It connects congress data, publication insights, expert intelligence, and evidence data into a single connected view, helping medical teams identify trends and generate actionable insights more efficiently.
Why is AI important in evidence generation?
AI can help healthcare and pharmaceutical teams process large volumes of scientific, clinical, and real-world data more efficiently. When combined with human scientific expertise, AI-enabled approaches can accelerate evidence synthesis, improve data integration, and support more informed decision-making.
Explore Bioscript Data Insights
Explore how Bioscript Data Insights helps pharmaceutical teams accelerate evidence generation, integrate complex healthcare data, and apply AI-enabled analytics to real-world scientific challenges.
Explore Bioscript Data Insights
